CLEARONE INC (CLRO) Fundamental Analysis & Valuation
NASDAQ:CLRO • US18506U2033
Current stock price
4.346 USD
+0.1 (+2.26%)
Last:
This CLRO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CLRO Profitability Analysis
1.1 Basic Checks
- In the past year CLRO has reported negative net income.
- CLRO had a negative operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: CLRO reported negative net income in multiple years.
- CLRO had negative operating cash flow in 4 of the past 5 years.
1.2 Ratios
- The Return On Assets of CLRO (-246.44%) is worse than 95.83% of its industry peers.
- CLRO's Return On Equity of -553.33% is on the low side compared to the rest of the industry. CLRO is outperformed by 89.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -246.44% | ||
| ROE | -553.33% | ||
| ROIC | N/A |
ROA(3y)-3.47%
ROA(5y)-4.24%
ROE(3y)-5.21%
ROE(5y)-5.91%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- CLRO has a Gross Margin of 10.42%. This is amonst the worse of the industry: CLRO underperforms 93.75% of its industry peers.
- CLRO's Gross Margin has declined in the last couple of years.
- CLRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.42% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.52%
GM growth 5Y-12.37%
2. CLRO Health Analysis
2.1 Basic Checks
- CLRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, CLRO has about the same amount of shares outstanding.
- The number of shares outstanding for CLRO has been increased compared to 5 years ago.
- CLRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -5.84, we must say that CLRO is in the distress zone and has some risk of bankruptcy.
- CLRO's Altman-Z score of -5.84 is on the low side compared to the rest of the industry. CLRO is outperformed by 75.00% of its industry peers.
- There is no outstanding debt for CLRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.84 |
ROIC/WACCN/A
WACC9.48%
2.3 Liquidity
- CLRO has a Current Ratio of 2.29. This indicates that CLRO is financially healthy and has no problem in meeting its short term obligations.
- CLRO has a Current ratio (2.29) which is in line with its industry peers.
- CLRO has a Quick Ratio of 2.19. This indicates that CLRO is financially healthy and has no problem in meeting its short term obligations.
- CLRO's Quick ratio of 2.19 is fine compared to the rest of the industry. CLRO outperforms 72.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.19 |
3. CLRO Growth Analysis
3.1 Past
- CLRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -429.02%.
- The Revenue for CLRO has decreased by -42.90% in the past year. This is quite bad
- CLRO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.58% yearly.
EPS 1Y (TTM)-429.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-513.95%
Revenue 1Y (TTM)-42.9%
Revenue growth 3Y-26.75%
Revenue growth 5Y-14.58%
Sales Q2Q%-100%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. CLRO Valuation Analysis
4.1 Price/Earnings Ratio
- CLRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. CLRO Dividend Analysis
5.1 Amount
- No dividends for CLRO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CLRO Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:CLRO (3/17/2026, 8:06:35 PM)
4.346
+0.1 (+2.26%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)11-13 2025-11-13
Earnings (Next)03-30 2026-03-30
Inst Owners4.71%
Inst Owner Change125.08%
Ins Owners0.09%
Ins Owner Change-8.86%
Market Cap9.74M
Revenue(TTM)7.18M
Net Income(TTM)-23.34M
Analysts85.71
Price TargetN/A
Short Float %0.22%
Short Ratio0.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend9.07
Dividend Growth(5Y)113.94%
DP-2.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.35 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.31 | ||
| P/tB | 2.31 | ||
| EV/EBITDA | N/A |
EPS(TTM)-13.65
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-3.33
FCFYN/A
OCF(TTM)-3.28
OCFYN/A
SpS3.21
BVpS1.88
TBVpS1.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -246.44% | ||
| ROE | -553.33% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 10.42% | ||
| FCFM | N/A |
ROA(3y)-3.47%
ROA(5y)-4.24%
ROE(3y)-5.21%
ROE(5y)-5.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.52%
GM growth 5Y-12.37%
F-Score3
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 20.41% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.19 | ||
| Altman-Z | -5.84 |
F-Score3
WACC9.48%
ROIC/WACCN/A
Cap/Depr(3y)41.23%
Cap/Depr(5y)32.53%
Cap/Sales(3y)2.06%
Cap/Sales(5y)1.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-429.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-513.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.9%
Revenue growth 3Y-26.75%
Revenue growth 5Y-14.58%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-115.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-115%
OCF growth 3YN/A
OCF growth 5YN/A
CLEARONE INC / CLRO Fundamental Analysis FAQ
What is the ChartMill fundamental rating of CLEARONE INC (CLRO) stock?
ChartMill assigns a fundamental rating of 2 / 10 to CLRO.
What is the valuation status of CLEARONE INC (CLRO) stock?
ChartMill assigns a valuation rating of 0 / 10 to CLEARONE INC (CLRO). This can be considered as Overvalued.
Can you provide the profitability details for CLEARONE INC?
CLEARONE INC (CLRO) has a profitability rating of 0 / 10.
Can you provide the financial health for CLRO stock?
The financial health rating of CLEARONE INC (CLRO) is 6 / 10.